Fibroblasts from Idiopathic Pulmonary Fibrosis and Normal Lungs Differ in Growth Rate, Apoptosis, and Tissue Inhibitor of Metalloproteinases Expression
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disorder characterized by fibroblast proliferation and extracellular matrix accumulation. However, studies on fibroblast growth rate and collagen synthesis have given contradictory results. Here we analyzed fibroblast growth rate by a formazan-based chromogenic assay; fibroblast apoptosis by in situ end labeling (ISEL) and propidium iodide staining; percent of alpha-smooth muscle actin (alpha-SMA) positive cells by fluorescence-activated cell sorter; and alpha1-(I) collagen, transforming growth factor (TGF)-beta1, collagenase-1, gelatinases A and B, and tissue inhibitor of metalloproteinase (TIMP)-1, -2, -3, and -4 expression by reverse transcriptase/polymerase chain reaction in fibroblasts derived from IPF and control lungs. Growth rate was significantly lower in IPF fibroblasts compared with controls (13.3 +/- 38.5% versus 294.6 +/- 57%, P < 0.0001 at 13 d). Conversely, a significantly higher percentage of apoptotic cells was observed in IPF-derived fibroblasts (ISEL: 31.9 +/- 7.0% versus 15.5 +/- 7.6% from controls; P < 0.008). alpha-SMA analysis revealed a significantly higher percentage of myofibroblasts in IPF samples (62.8 +/- 25.2% versus 14.8 +/- 11.7% from controls; P < 0.01). IPF fibroblasts were characterized by an increase in pro-alpha1-(I) collagen, TGF-beta1, gelatinase B, and all TIMPs' gene expression, whereas collagenase-1 and gelatinase A expression showed no differences. These results suggest that fibroblasts from IPF exhibit a profibrotic secretory phenotype, with lower growth rate and increased spontaneous apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue inhibitors of metalloproteinases: evolution, structure and function
Brew, K., Dinakarpandian, D., & Nagase, H. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00279-4 · Cited by 1,908
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Gomez, D. E., Alonso, D. F., Yoshiji, H., & Thorgeirsson, U. P. (1997) · PubMed · Cited by 1,508
Peterkofsky, B., & Diegelmann, R. (1971) · Biochemistry · doi:10.1021/bi00782a009 · Cited by 1,379
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
Gorczyca, W., GONG, J., & Darżynkiewicz, Z. (1993) · PubMed · Cited by 982
Zhang, K., Rekhter, M. D., Gordon, D., & Phan, S. H. (1994) · PubMed · Cited by 480
Kuhn, C., & McDonald, J. A. (1991) · PubMed · Cited by 472
Matrix Metalloproteinase Expression and Production by Alveolar Macrophages in Emphysema
FINLAY, G. A., O'DRISCOLL, L. R., RUSSELL, K. J., D'ARCY, E. M., MASTERSON, J. B., FITZGERALD, M. X., & O'CONNOR, C. M. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.1.9612018 · Cited by 440
Selman, M., Ruiz, V., Cabrera, S., Segura, L., Ramírez, R., Barrios, R., & Pardo, A. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.3.l562 · Cited by 425
Self-citationAngiotensin II Induces Apoptosis of Adult Ventricular MyocytesIn Vitro
Kajstura, J., Cigola, E., Malhotra, A., Li, P., Cheng, W., Meggs, L. G., & Anversa, P. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0333 · Cited by 413
Cited by
Integrating mechanisms of pulmonary fibrosis
Wynn, T. A. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110551 · Cited by 1,274
Type 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055
Pathogenesis of Idiopathic Pulmonary Fibrosis
Wolters, P. J., Collard, H. R., & Jones, K. D. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104706 · Cited by 862
Pulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822
Mechanisms of Pulmonary Fibrosis
Thannickal, V. J., Toews, G. B., White, E. S., Lynch III, J. P., & Martinez, F. J. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.103810 · Cited by 808
Bachmayr-Heyda, A., Reiner, A. T., Auer, K., Sukhbaatar, N., Aust, S., Bachleitner-Hofmann, T., Mesteri, I., Grunt, T. W., Zeillinger, R., & Pils, D. (2015) · Scientific Reports · doi:10.1038/srep08057 · Cited by 736
Wollin, L., Maillet, I., Quesniaux, V., Holweg, A., & Ryffel, B. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208223 · Cited by 633
Pulmonary fibrosis: patterns and perpetrators
Noble, P. W., Barkauskas, C. E., & Jiang, D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60323 · Cited by 595
Matrix Metalloproteinase-9 in Lung Remodeling
Atkinson, J. J., & Senior, R. M. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0166tr · Cited by 587
Metformin reverses established lung fibrosis in a bleomycin model
Rangarajan, S., Bone, N. B., Zmijewska, A. A., Jiang, S., Park, D. W., Bernard, K., Locy, M. L., Ravi, S., Deshane, J., Mannon, R. B., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0087-6 · Cited by 560
Fibrotic extracellular matrix activates a profibrotic positive feedback loop
Parker, M. W., Rossi, D., Peterson, M., Smith, K., Sikström, K., White, E. S., Connett, J. E., Henke, C. A., Larsson, O., & Bitterman, P. B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71386 · Cited by 548
Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis
Pardo, A., Gibson, K., Cisneros, J., Richards, T. J., Yang, Y., Becerril, C., Yousem, S., Herrera, I., Ruiz, V., Selman, M., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020251 · Cited by 489
Self-citationFibroblast heterogeneity: implications for human disease
Lynch, M. D., & Watt, F. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93555 · Cited by 480
Meltzer, E. B., & Noble, P. W. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-8 · Cited by 407
Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis
Chaudhary, N. I., Roth, G. J., Hilberg, F., Müller-Quernheim, J., Prasse, A., Zissel, G., Schnapp, A., & Park, J. E. (2007) · European Respiratory Journal · doi:10.1183/09031936.00152106 · Cited by 386
Mitochondrial Reactive Oxygen Species Regulate Transforming Growth Factor-β Signaling
Jain, M., Rivera, S., Monclus, E. A., Synenki, L., Zirk, A., Eisenbart, J., Feghali-Bostwick, C., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.431973 · Cited by 381
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
Selman, M., & Pardo, A. (2001) · Respiratory Research · doi:10.1186/rr175 · Cited by 379
Self-citationEvolving Concepts of Apoptosis in Idiopathic Pulmonary Fibrosis
Thannickal, V. J., & Horowitz, J. C. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-001tk · Cited by 364
Pharmacologic Differentiation of Inflammation and Fibrosis in the Rat Bleomycin Model
Chaudhary, N. I., Schnapp, A., & Park, J. E. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-717oc · Cited by 358
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
Phan, T. H. G., Paliogiannis, P., Nasrallah, G. K., Giordo, R., Eid, A. H., Fois, A. G., Zinellu, A., Mangoni, A. A., & Pintus, G. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03693-7 · Cited by 351
Amara, N., Goven, D., Prost, F., Muloway, R., Crestani, B., & Boczkowski, J. (2010) · Thorax · doi:10.1136/thx.2009.113456 · Cited by 337
Chilosi, M., Carloni, A., Rossi, A., & Poletti, V. (2013) · Translational Research · doi:10.1016/j.trsl.2013.06.004 · Cited by 317
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
Ballester, B., Milara, J., & Cortijo, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030593 · Cited by 308
The IL-1 cytokine family and its role in inflammation and fibrosis in the lung
Borthwick, L. A. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0559-z · Cited by 294
MATRIX METALLOPROTEINASE-2 (MMP-2) AND MMP-9 IN PULMONARY PATHOLOGY
Chakrabarti, S., & Patel, K. D. (2005) · Experimental Lung Research · doi:10.1080/019021490944232 · Cited by 279
Lung Remodeling in Pulmonary Tuberculosis
Dheda, K., Booth, H., Huggett, J. F., Johnson, M. A., Zumla, A., & Rook, G. A. W. (2005) · The Journal of Infectious Diseases · doi:10.1086/444545 · Cited by 274
Epigenetic Regulation of miR-17∼92 Contributes to the Pathogenesis of Pulmonary Fibrosis
Dakhlallah, D., Batte, K., Wang, Y., Cantemir-Stone, C. Z., Yan, P., Nuovo, G., Mikhail, A., Hitchcock, C. L., Wright, V. P., Nana-Sinkam, S. P., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201205-0888oc · Cited by 267
The Prostanoid EP4 Receptor and Its Signaling Pathway
Yokoyama, U., Iwatsubo, K., Umemura, M., Fujita, T., & Ishikawa, Y. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007195 · Cited by 264
Participation of miR-200 in Pulmonary Fibrosis
Yang, S., Banerjee, S., de Freitas, A., Sanders, Y. Y., Ding, Q., Matalon, S., Thannickal, V. J., Abraham, E., & Liu, G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.10.005 · Cited by 259
Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis
Pardo, A., & Selman, M. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201605-341aw · Cited by 204
Self-citationYanai, H., Shteinberg, A., Porat, Z., Budovsky, A., Braiman, A., Zeische, R., & Fraifeld, V. E. (2015) · Aging · doi:10.18632/aging.100807 · Cited by 198
Batra, V., Musani, A. I., Hastie, A. T., Khurana, S., Carpenter, K. A., Zangrilli, J. G., & Peters, S. P. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.01885.x · Cited by 177
Barkauskas, C. E., & Noble, P. W. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00321.2013 · Cited by 167
Moodley, Y. P., Scaffidi, A. K., Misso, N. L., Keerthisingam, C., McAnulty, R. J., Laurent, G. J., Mutsaers, S. E., Thompson, P. J., & Knight, D. A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63658-9 · Cited by 165
Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4
Jiang, D., Liang, J., Campanella, G. S., Guo, R., Yu, S., Xie, T., Liu, N., Jung, Y., Homer, R., Meltzer, E. B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38644 · Cited by 159
Idiopathic pulmonary fibrosis: new insights in its pathogenesis
Pardo, A., & Selman, M. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00091-2 · Cited by 140
Organ, L. A., Duggan, A.-M. R., Oballa, E., Taggart, S. C., Simpson, J. K., Kang’ombe, A. R., Braybrooke, R., Molyneaux, P. L., North, B., Karkera, Y., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1118-7 · Cited by 139
“Intriguingly, whilst increases in collagen type-1 production are associated with TGFβ- activation of IPF fibroblasts [25], and have been observed in IPF lung [26], we did not find elevated levels of collagen type 1 synthesis neoeptiopes in the serum of IPF subjects.”
BackgroundLehtonen, S. T., Veijola, A., Karvonen, H., Lappi-Blanco, E., Sormunen, R., Korpela, S., Zagai, U., Sköld, M. C., & Kaarteenaho, R. (2016) · Respiratory Research · doi:10.1186/s12931-016-0328-5 · Cited by 133
“It has also been reported that fibroblastic cells from IPF patients have a higher amount of α-SMA, a lower growth rate and a higher number of apoptotic cells than found in controls [14].”
Biomarkers in idiopathic pulmonary fibrosis
Drakopanagiotakis, F., Wujak, L., Wygrecka, M., & Markart, P. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.023 · Cited by 132
Pechkovsky, D. V., Prêle, C. M., Wong, J., Hogaboam, C. M., McAnulty, R. J., Laurent, G. J., Zhang, S. S.-M., Selman, M., Mutsaers, S. E., & Knight, D. A. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.12.022 · Cited by 127
Self-citationChoi, Y.-M., Lee, H., Ann, M., Song, M., Rheey, J., & Jang, J. (2023) · Biofabrication · doi:10.1088/1758-5090/acd95f · Cited by 94
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression
Jones, D. L., Haak, A. J., Caporarello, N., Choi, K. M., Ye, Z., Yan, H., Varelas, X., Ordog, T., Ligresti, G., & Tschumperlin, D. J. (2019) · Journal of Cell Science · doi:10.1242/jcs.233486 · Cited by 77
“Fibroblasts cultured from IPF lung tissue exhibit altered proliferation and excess extracellular matrix (ECM) deposition that persists stably in cell culture (Moodley et al., 2003; Ramos et al., 2001).”
BackgroundPulmonary fibrosis: Emerging diagnostic and therapeutic strategies
Selvarajah, B., Platé, M., & Chambers, R. C. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101227 · Cited by 57
p53 Expression in Lung Fibroblasts Is Linked to Mitigation of Fibrotic Lung Remodeling
Nagaraja, M. R., Tiwari, N., Shetty, S. K., Marudamuthu, A. S., Fan, L., Ostrom, R. S., Fu, J., Gopu, V., Radhakrishnan, V., Idell, S., et al. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2018.07.005 · Cited by 37
Zheng, Y., Schupp, J., Adams, T., Clair, G., Justet, A., Ahangari, F., Yan, X., Hansen, P., Carlon, M., Cortesi, E., et al. (2023) · doi:10.21203/rs.3.rs-3676579/v1 · Cited by 34
Li, W., Sparks, R. P., Sun, C., Yang, Y., Pantano, L., Kirchner, R., Arghiani, N., Weilheimer, A., Toles, B. J., Chen, J. Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56900-z · Cited by 5
Metadata
- Authors
- Ramos, C., Montaño, M., Garcı́a-Alvarez, J., Ruiz, V., Uhal, B. D., Selman, M., & Pardo, A.
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-05-01
- Volume
- 24
- Issue
- 5
- Pages
- 591-598
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W1988272762
- Cited by
- 363
- References
- 34
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.